Scarica l'app Stockscreener
3.63
2.42%
-0.09
Dopo l'orario di chiusura:
3.55
-0.08
-2.20%
Precedente Chiudi:
$3.72
Aprire:
$3.72
Volume 24 ore:
225.70K
Relative Volume:
0.56
Capitalizzazione di mercato:
$156.98M
Reddito:
-
Utile/perdita netta:
$-110.66M
Rapporto P/E:
-1.1724
EPS:
-3.0963
Flusso di cassa netto:
$-97.76M
1 W Prestazione:
-1.89%
1M Prestazione:
+7.72%
6M Prestazione:
+38.02%
1 anno Prestazione:
-51.28%
Intervallo 1D:
$3.55
$3.7789
Intervallo di 1 settimana:
$3.55
$4.11
Portata 52W:
$1.78
$7.85
Kyverna Therapeutics Inc Stock (KYTX) Company Profile
Nome
Kyverna Therapeutics Inc
Settore
Industria
Telefono
(510) 626-8331
Indirizzo
5980 HORTON STREET, EMERYVILLE
Confronta KYTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KYTX
Kyverna Therapeutics Inc
|
3.63 | 155.25M | 0 | -110.66M | -97.76M | -3.0963 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Kyverna Therapeutics Inc Stock (KYTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-20 | Iniziato | William Blair | Outperform |
| 2025-05-27 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-10-10 | Iniziato | UBS | Buy |
| 2024-10-09 | Iniziato | Rodman & Renshaw | Buy |
| 2024-07-03 | Iniziato | H.C. Wainwright | Neutral |
| 2024-03-04 | Iniziato | JP Morgan | Overweight |
| 2024-03-04 | Iniziato | Leerink Partners | Outperform |
| 2024-03-04 | Iniziato | Morgan Stanley | Overweight |
| 2024-03-04 | Iniziato | Wells Fargo | Overweight |
Mostra tutto
Kyverna Therapeutics Inc Borsa (KYTX) Ultime notizie
Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives $15.60 Consensus PT from Brokerages - MarketBeat
Is Kyverna Therapeutics Inc. benefiting from interest rate changesQuarterly Profit Review & AI Powered Buy/Sell Recommendations - khodrobank.com
Should you wait for a breakout in Kyverna Therapeutics Inc.Market Activity Recap & Real-Time Market Trend Scan - Newser
Real time social sentiment graph for Kyverna Therapeutics Inc.Quarterly Portfolio Report & Low Volatility Stock Recommendations - Newser
Trend analysis for Kyverna Therapeutics Inc. this week2025 Price Momentum & Scalable Portfolio Growth Methods - Newser
Visual trend scoring systems applied to Kyverna Therapeutics Inc.Portfolio Value Summary & Consistent Profit Trading Strategies - Newser
Strategies to average down on Kyverna Therapeutics Inc.Quarterly Profit Report & AI Driven Price Forecasts - Newser
Will earnings trigger a reversal in Kyverna Therapeutics Inc.Portfolio Value Report & Stepwise Swing Trade Plans - Newser
Regression analysis insights on Kyverna Therapeutics Inc. performanceMarket Sentiment Review & Technical Entry and Exit Alerts - Newser
How to read the order book for Kyverna Therapeutics Inc.Weekly Investment Report & Safe Entry Point Identification - Newser
Understanding Kyverna Therapeutics Inc.’s price movementPortfolio Value Report & Growth Focused Entry Reports - Newser
Can Kyverna Therapeutics Inc. outperform under higher oil pricesJuly 2025 Opening Moves & Safe Capital Investment Plans - khodrobank.com
Applying big data sentiment scoring on Kyverna Therapeutics Inc.2025 Top Gainers & Daily Oversold Bounce Ideas - Newser
Relative strength of Kyverna Therapeutics Inc. in sector analysisJuly 2025 WrapUp & Real-Time Market Sentiment Reports - Newser
What is the target price for Kyverna Therapeutics Inc. stockDollar Strength & Smart Money Movement Tracker - khodrobank.com
Is Kyverna Therapeutics Inc. stock risky to hold now2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - khodrobank.com
Kyverna Therapeutics Inc. stock prediction for this weekMarket Weekly Review & High Conviction Buy Zone Picks - Newser
Ranking Kyverna Therapeutics Inc. among high performing stocks via toolsJuly 2025 Macro Moves & Free Expert Verified Stock Movement Alerts - Newser
What is the earnings history of Kyverna Therapeutics Inc.2025 Macro Impact & Safe Swing Trade Setup Alerts - khodrobank.com
‘FDA-aligned’ trial of KYV-101 for MG likely to start enrolling this year - Myasthenia Gravis News
Automated trading signals detected on Kyverna Therapeutics Inc.Dip Buying & AI Enhanced Trading Alerts - Newser
Is Kyverna Therapeutics Inc. stock poised for growthWeekly Trade Review & Daily Oversold Stock Bounce Ideas - Newser
Is Kyverna Therapeutics Inc. stock a good pick for beginnersTrade Performance Summary & Safe Entry Point Alerts - خودرو بانک
Published on: 2025-09-02 01:21:00 - Newser
Kyverna Therapeutics Inc. recovery potential after sell offMarket Rally & Real-Time Volume Analysis Alerts - Newser
Will Kyverna Therapeutics Inc. continue its uptrendTrade Exit Report & Technical Entry and Exit Alerts - Newser
Aug Reactions: What is the target price for Kyverna Therapeutics Inc. stockAnalyst Downgrade & High Accuracy Swing Trade Signals - khodrobank.com
Volatility clustering patterns for Kyverna Therapeutics Inc.Market Activity Recap & Technical Analysis for Trade Confirmation - Newser
Using Bollinger Bands to evaluate Kyverna Therapeutics Inc.Market Growth Report & Expert Approved Momentum Trade Ideas - Newser
Is Kyverna Therapeutics Inc. stock reversal real or fakeGold Moves & Accurate Intraday Trade Tips - Newser
Real time scanner hits for Kyverna Therapeutics Inc. explainedJuly 2025 Sector Moves & Short-Term High Return Ideas - Newser
Measuring Kyverna Therapeutics Inc.’s beta against major indicesMarket Volume Summary & Stepwise Entry/Exit Trade Alerts - Newser
What does recent volatility data suggest for Kyverna Therapeutics Inc.Quarterly Performance Summary & High Yield Equity Trading Tips - Newser
Kyverna Therapeutics Inc. stock trend forecastQuarterly Performance Summary & AI Powered Buy and Sell Recommendations - Newser
Can swing trading help recover from Kyverna Therapeutics Inc. lossesGap Down & AI Driven Stock Reports - Newser
Will Kyverna Therapeutics Inc. bounce back from current supportEarnings Recap Report & Technical Confirmation Trade Alerts - Newser
Kyverna Therapeutics Inc Azioni (KYTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):